CureSight Apparat Ta 'trattament Tal-Għajnejn Għażżien minn Kobi Kor

Id-disinn CureSight Apparat Ta 'trattament Tal-Għajnejn Għażżien minn Kobi Kor huwa rebbieħ stmat ħafna tal-prestiġjuż 2022 Premju A' Design Award tal-Ħadid fil-Kategorija tal-Kompetizzjoni ta' Disinn ta' Apparati u Tagħmir Mediku.

ĦadidProdott Mediku· 2022

CureSight Apparat Ta 'trattament Tal-Għajnejn Għażżien

minn Kobi Kor

Klijent: Novasight

Rebbieħ tal-Premju A' Design Award tal-Ħadid fil-Kategorija ta' Prodott Mediku

22,237

Rebbieħ ta' Premju Ivverifikat

Ivverifika l-Istatus tal-Premju għal #133911

Skopri Issa Żur is-Sit Ara fuq A' Design Award Stqarrija għall-Istampa Badge tal-Premju

Kuluri

Id-Disinn

Dwar CureSight Apparat Ta 'trattament Tal-Għajnejn Għażżien

Il-proċess tad-disinn ta 'CureSight iffoka fuq il-ħolqien ta' prodott u soluzzjoni ta 'trattament li se jagħmel impatt soċjali pożittiv u jgħin lill-pazjenti, li ħafna minnhom huma tfal, biex jevitaw l-iskumdità u l-imbarazzament involuti fit-trattament tradizzjonali bil-garża tal-għajnejn. Id-disinn jenfasizza wkoll li d-dehra u s-sensazzjoni tal-prodott huma essenzjali biex jimmotivaw u jagħtu s-setgħa lit-tfal. L-ispirazzjoni għad-disinn tal-grafika ġiet mill-aġġeġġi tat-teknoloġija li t-tfal iħobbu jużaw u jilagħbu miegħu. Id-disinn tal-forma jipprovdi dehra roqgħa u moderna għal prodott ta 'apparat mediku.

Ir-Rikonoxximent

Dwar il-Premju A' Design Award tal-Ħadid

CureSight Apparat Ta 'trattament Tal-Għajnejn Għażżien huwa rebbieħ tal-Premju A' Design Award tal-Ħadid, rikonoxximent prestiġjuż mogħti lil disinji tajbin li jissodisfaw ir-rekwiżiti professjonali u industrijali mistennija minn ħolqien imfassal tajjeb. Ir-rebbieħa tal-Ħadid juru l-ħila kbira, l-ispeċjalizzazzjoni għolja, il-fehim espert u l-kapaċità kreattiva tal-ħallieqa tagħhom. Huwa mistenni li CureSight Apparat Ta 'trattament Tal-Għajnejn Għażżien ikun ħolqien imqabbar ħafna, mammirat u maħbub li huwa prattiku u innovattiv. Dan id-disinn rebbieħ tal-Ħadid jintegra l-aħjar prattiki tal-industrija u għandu karatteristiċi tekniċi kompetenti marbuta mal-għarfien u t-talent. CureSight Apparat Ta 'trattament Tal-Għajnejn Għażżien huwa rispettat għall-eżattezza tiegħu u mfassal biex itejjeb il-kwalità tal-ħajja u jgħin jagħmel id-dinja post aħjar.

Wara d-Disinn

Kit għall-Istampa

Krediti, membri tat-tim u dettalji tekniċi pprovduti mid-disinjatur.

Proprjetajiet Uniċi: The curesight is a powerful solution with great potential to totally change the treatment of lazy eye condition, with the important advantage of treating the lazy eye from the comfort of home and by watching any tv or streaming video content.
This healthcare solution for lazy eye condition integrates high-end technologies for eye-tracking and ai software tools for smart analyzing of the lazy eye condition and providing personal custom treatment. The gold standard care for lazy eye is placing a patch over the strong eye, an old-fashioned solution that suffers from very low compliance.
Dimensjonijiet u Ippakkjar: product net dimensions
Height 230mm
Width 390mm
Depth 60mm
Tikketti: amlyopia, lazy eye, medical device, product design, social impact, degital healthcare
Teknoloġija tal-Produzzjoni: The design activity started with a brainstorming meeting to learn more about the problem from the clinical and user needs aspects, and to outline the main big limitations of today's treatment methods.
We also discussed the ergonomics and usability needs to be able to provide the best treatment.
during the design process, we tested several design concepts both aesthetically and with physical mockups,
Production technologies include aluminum CNC machining and anodize plating, for the front bezel and plastic injection for the back cover and small covers.
Sfida tad-Disinn: The creative challenge was to dress the unique technology components with style and to provide a good user experience to the users, the specific usability needs to enable good treatment for various populations and make it an appealing and empowering treatment device, and lead to important social impact
Riċerka: Following an intense effort over the last 18 months, the company officially announced that the company successfully met the primary endpoint of the CureSight randomized, controlled pivotal trial of amblyopia treatment against the gold standard patching.
This is the first-ever pivotal study in which a digital device was shown to be non-inferior to eye patching for amblyopia treatment in children.
The study also exhibited 93% adherence to the curesight treatment, as well as a 93% likelihood of the parents choosing curesight over patching.
Ispirazzjoni: The inspiration for the curesight product started from a personal experience when one of my kids needed to treat the lazy eye condition with the eye patch solution, I learned from this experience about the discomfort of wearing the eye patch for a few hours every day and especially how embarrassing it is from the social point of view.
The inspiration for the styling design came from the tech gadgets that kids love to use and play with, to provide a slick and modern design to a medical device product type, the front aluminum bezel, and the back swallowtail gives the product a clean gadget look.
Tul tal-Proġett: The project started in 2019 in Tel Aviv, and finished in late 2021, the project was exhibited at the CES in January 2020 in Las Vegas
Fluss tal-Operazzjoni: The patient, most likely kids will have the fun be treated by the Curesight while watching any video content they love to watch without any degradation in quality and from the comfort of home.
Membri tat-Tim: Kobi Kor
Tal Samet
Krediti tal-Immaġni: All images
Photograph and Illustrations: Novasight and Kobi Kor